BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 30851011)

  • 1. Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects.
    Antonio L; Caerels S; Jardi F; Delaunay E; Vanderschueren D
    Andrology; 2019 May; 7(3):302-306. PubMed ID: 30851011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of testosterone treatment on bone mineral density in Klinefelter syndrome: A retrospective cohort study.
    Willems S; David K; Decallonne B; Marcq P; Antonio L; Vanderschueren D
    Andrology; 2023 Oct; 11(7):1295-1302. PubMed ID: 36792918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis in men with hypogonadism because of ApoA-I Leu75Pro amyloidosis under long-term testosterone therapy.
    Facondo P; Delbarba A; Pezzaioli LC; Ferlin A; Cappelli C
    Andrology; 2023 Sep; 11(6):1077-1085. PubMed ID: 36624081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compromised Volumetric Bone Density and Microarchitecture in Men With Congenital Hypogonadotropic Hypogonadism.
    Ostertag A; Papadakis GE; Collet C; Trabado S; Maione L; Pitteloud N; Bouligand J; De Vernejoul MC; Cohen-Solal M; Young J
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3312-e3326. PubMed ID: 33725720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study.
    Aversa A; Bruzziches R; Francomano D; Greco EA; Fornari R; Di Luigi L; Lenzi A; Migliaccio S
    Aging Male; 2012 Jun; 15(2):96-102. PubMed ID: 22439807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effect of testosterone replacement therapy on bone in hypogonadal men with Klinefelter Syndrome.
    Tahani N; Nieddu L; Prossomariti G; Spaziani M; Granato S; Carlomagno F; Anzuini A; Lenzi A; Radicioni AF; Romagnoli E
    Endocrine; 2018 Aug; 61(2):327-335. PubMed ID: 29696556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study).
    Shigehara K; Konaka H; Koh E; Nakashima K; Iijima M; Nohara T; Izumi K; Kitagawa Y; Kadono Y; Sugimoto K; Iwamoto T; Mizokami A; Namiki M
    Aging Male; 2017 Sep; 20(3):139-145. PubMed ID: 28347184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alendronate for osteoporosis in men with androgen-repleted hypogonadism.
    Shimon I; Eshed V; Doolman R; Sela BA; Karasik A; Vered I
    Osteoporos Int; 2005 Dec; 16(12):1591-6. PubMed ID: 16362147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adequacy of androgen replacement influences bone density response to testosterone in androgen-deficient men.
    Aminorroaya A; Kelleher S; Conway AJ; Ly LP; Handelsman DJ
    Eur J Endocrinol; 2005 Jun; 152(6):881-6. PubMed ID: 15941928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior testosterone replacement therapy may impact spermatogenic response to combined gonadotropin therapy in severe congenital hypogonadotropic hypogonadism.
    Shah R; Patil V; Sarathi V; Lila AR; Zacharin M; Krishnappa B; Sehemby M; Jaiswal SK; Jadhav PL; Ramteke-Jadhav S; Shah N; Bandgar T
    Pituitary; 2021 Jun; 24(3):326-333. PubMed ID: 33226541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism.
    Laitinen EM; Hero M; Vaaralahti K; Tommiska J; Raivio T
    Int J Androl; 2012 Aug; 35(4):534-40. PubMed ID: 22248317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome.
    Ferlin A; Selice R; Di Mambro A; Ghezzi M; Di Nisio A; Caretta N; Foresta C
    Osteoporos Int; 2015 Aug; 26(8):2193-202. PubMed ID: 25963234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism.
    Tirabassi G; delli Muti N; Gioia A; Biagioli A; Lenzi A; Balercia G
    J Endocrinol Invest; 2014 Apr; 37(4):393-400. PubMed ID: 24458833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density outcomes following long-term treatment with subcutaneous testosterone pellet implants in male hypogonadism.
    Zacharin MR; Pua J; Kanumakala S
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):691-5. PubMed ID: 12780744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Bone Mineral Density in Male Patients With Idiopathic Hypogonadotropic Hypogonadism Who Undergo Sex Hormone Therapy: Findings From Cross-Sectional and Longitudinal Studies.
    Zhang R; Mao J; Wang X; Nie M; Ma W; Ji W; Yu B; Huang Q; Wu X
    Endocr Pract; 2021 Sep; 27(9):934-940. PubMed ID: 34000389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density.
    Dabaja AA; Bryson CF; Schlegel PN; Paduch DA
    BJU Int; 2015 Mar; 115(3):480-5. PubMed ID: 25046796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of testosterone replacement therapy on vitamin D and FGF-23 levels in congenital hypogonadism.
    Haymana C; Sonmez A; Aydogdu A; Tapan S; Basaran Y; Meric C; Baskoy K; Taslipinar A; Yilmaz MI; Azal O
    Endokrynol Pol; 2017; 68(3):311-616. PubMed ID: 28230890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches.
    Anapliotou ML; Kastanias IT; Psara P; Evangelou EA; Liparaki M; Dimitriou P
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):279-87. PubMed ID: 7758233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of immunosuppression-induced hypogonadism on bone metabolism after heart transplantation].
    Stief J; Sohn HY; Alt A; Uberfuhr P; Theisen K; Stempfle HU
    Dtsch Med Wochenschr; 2004 Jul; 129(31-32):1674-8. PubMed ID: 15273918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone involvement in males with Kallmann disease.
    Iolascon G; Frizzi L; Bianco M; Gimigliano F; Palumbo V; Sinisi AM; Sinisi AA
    Aging Clin Exp Res; 2015 Oct; 27 Suppl 1():S31-6. PubMed ID: 26201943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.